Four symptom dimensions in outpatients with schizophrenia

Comprehensive Psychiatry

Volumn 47, Issue 5, 2006, Pages 384-388

  Villalta Gil, Victòria ^a   Vilaplana, Miriam ^a   Ochoa, Susana ^a   Dolz, Montserrat ^a   Usall, Judith ^a   Haro, Josep Maria ^a   Almenara, José ^b   González, Juan Luis ^b   Lagares, Carolina ^b  

^a Research and Development Unit   (Spain)

^b UNIVERSITY OF CÁDIZ   (Spain)

Author keywords

Positive and Negative Syndrome Scale (PANSS); Principal component analysis; Psychopathology; Schizophrenia

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DISABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH CENTER; NEGATIVE SYNDROME; OUTPATIENT; POSITIVE SYNDROME; PRINCIPAL COMPONENT ANALYSIS; QUESTIONNAIRE; RANDOMIZATION; RATING SCALE; REGISTER; SCHIZOPHRENIA; SOCIAL STATUS; SPAIN; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; COMMUNITY MENTAL HEALTH CENTERS; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; PRINCIPAL COMPONENT ANALYSIS; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; REGISTRIES; SCHIZOPHRENIC PSYCHOLOGY;

EID: 33747053934     PISSN: 0010440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.comppsych.2006.01.005     Document Type: Article

References (30)

1. Kraepelin E. Dementia praecox and paraphrenia (1919), Robert E. Krieger Publishing, Huntington (NY)
2. Crow T.J. Molecular pathology of schizophrenia: more than one disease process?. BMJ 280 6207 (1980) 66-68
3. Kay S.R., Fiszbein A., and Opler L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 13 2 (1987) 261-276
4. Strauss J.S., Carpenter Jr. W.T., and Bartko J.J. The diagnosis and understanding of schizophrenia: Part III. Speculations on the processes that underlie schizophrenic symptoms and signs. Schizophr Bull 11 (1974) 61-69
5. Liddle P.F. The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy. Br J Psychiatry 151 (1987) 145-151
6. Peralta V., de Leon J., and Cuesta M.J. Are there more than two syndromes in schizophrenia? A critique of the positive-negative dichotomy. Br J Psychiatry 161 (1992) 335-343
7. Kay S.R., and Sevy S. Pyramidical model of schizophrenia. Schizophr Bull 16 3 (1990) 537-545
8. Lindenmayer J.P., Bernstein-Hyman R., and Grochowski S. Five-factor model of schizophrenia. Initial validation. J Nerv Ment Dis 182 11 (1994) 631-638
9. Nakaya M., Suwa H., and Ohmori K. Latent structures underlying schizophrenic symptoms: a five-dimensional model. Schizophr Res 39 1 (1999) 39-50
10. Ochoa S., Haro J.M., Autonell J., Pendas A., Teba F., and Marquez M. Met and unmet needs of schizophrenia patients in a Spanish sample. Schizophr Bull 29 2 (2003) 201-210
11. Peralta V., and Cuesta M.J. Validación de la escala de los síndromes positivo y negativo (PANSS) en una muestra de esquizofrénicos españoles. Actas Luso-Esp Neurol Psiquiatr 22 4 (1994) 171-177
12. Sartorius N., Jablensky A., Korten A., Ernberg G., Anker M., Cooper J.E., et al. Early manifestations and first-contact incidence of schizophrenia in different cultures. A preliminary report on the initial evaluation phase of the WHO Collaborative Study on determinants of outcome of severe mental disorders. Psychol Med 16 4 (1986) 909-928
13. World Health Organization. ICD-10: International Classification of Diseases, Mental and Behaviour Disorders. 10th ed. (1992), Switzerland, Geneva
14. Endicott J., Spitzer R.L., Fleiss J.L., and Cohen J. The Global Assessment Scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 33 6 (1976) 766-771
15. American Psychiatric Association. DSM-IV-TR. Diagnostic and statistical manual of mental disorders (2000), APA, Washington
16. SPSS for Windows (2002), SPSS Inc, Chicago, Ill
17. Peralta V., Cuesta M.J., and de Leon J. An empirical analysis of latent structures underlying schizophrenic symptoms: a four-syndrome model. Biol Psychiatry 36 11 (1994) 726-736
18. Dollfus S., and Everitt B. Symptom structure in schizophrenia: two-, three- or four-factor models?. Psychopathology 31 3 (1998) 120-130
19. Loas G., Noisette C., Legrand A., and Delahousse J. A four-dimensional model of chronic schizophrenia based on the factorial structure of the Positive and Negative Syndrome Scale (PANSS). A study of a group of 153 chronic schizophrenic patients and comparison with the factorial structure of the BPRS. Encephale 23 1 (1997) 10-18
20. Feldman P.D., Kaiser C.J., Kennedy J.S., Sutton V.K., Tran P.V., Tollefson G.D., et al. Comparison of risperidone and olanzapine in the control of negative symptoms of chronic schizophrenia and related psychotic disorders in patients aged 50 to 65 years. J Clin Psychiatry 64 9 (2003) 998-1004
21. Miller A.L. Combination treatments for schizophrenia. CNS Spectr 9 9 Suppl 9 (2004) 19-23
22. Rueter L.E., Ballard M.E., Gallagher K.B., Basso A.M., Curzon P., and Kohlhaas K.L. Chronic low dose risperidone and clozapine alleviate positive but not negative symptoms in the rat neonatal ventral hippocampal lesion model of schizophrenia. Psychopharmacology (Berl) 176 3-4 (2004) 312-319
23. Addington J., and Addington D. Neurocognitive and social functioning in schizophrenia. Schizophr Bull 25 1 (1999) 173-182
24. Dickinson D., and Coursey R.D. Independence and overlap among neurocognitive correlates of community functioning in schizophrenia. Schizophr Res 56 1-2 (2002) 161-170
25. Muller M.J., Kienzle B., and Dahmen N. Depression, emotional blunting, and akinesia in schizophrenia overlap and differentiation. Eur J Health Econ 3 Suppl 2 (2002) s99-s103
26. Kelly D.L., Shim J.C., Feldman S.M., Yu Y., and Conley R.R. Lifetime psychiatric symptoms in persons with schizophrenia who died by suicide compared to other means of death. J Psychiatr Res 38 5 (2004) 531-536
27. Kontaxakis V., Havaki-Kontaxaki B., Margariti M., Stamouli S., Kollias C., and Christodoulou G. Suicidal ideation in inpatients with acute schizophrenia. Can J Psychiatry 49 7 (2004) 476-479
28. Hofer A., Kemmler G., Eder U., Edlinger M., Hummer M., and Fleischhacker W.W. Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects. J Clin Psychiatry 65 7 (2004) 932-939
29. Serretti A., Mandelli L., Lattuada E., and Smeraldi E. Depressive syndrome in major psychoses: a study on 1351 subjects. Psychiatry Res 127 1-2 (2004) 85-99
30. Ertugrul A., and Ulug B. The influence of neurocognitive deficits and symptoms on disability in schizophrenia. Acta Psychiatr Scand 105 3 (2002) 196-201